GMO Research & AI, Inc. Faces Valuation Challenges Amid Mixed Financial Performance

GMO Research & AI, Inc., a microcap company in the miscellaneous industry, has recently undergone an adjustment in its evaluation. This revision reflects a notable shift in its valuation metrics, which are critical indicators of the company's financial health and market position. The stock currently presents a P/E ratio of 323, indicating a high valuation relative to earnings. Additionally, the Price to Book Value stands at 6.21, suggesting that the stock is trading at a premium compared to its peers. The EV to EBIT ratio is reported at 402.32, while the EV to EBITDA is at 77.27, both of which highlight the company's elevated valuation levels. Despite these metrics, GMO Research & AI, Inc. has demonstrated a low return on equity (ROE) of 1.92% and a return on capital employed (ROCE) of 3.08%. The company has shown positive financial performance in the quarter ending December 2025, with net sales growth of 8.8% and a net profit of JPY 174.99 million. However, it has also faced challenges, including a significant decline in profits over the past year. Overall, the adjustment in evaluation reflects the complexities of GMO Research & AI, Inc.'s financial landscape, characterized by high valuation ratios and mixed performance indicators. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.